Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 22, 2019Molecular PharmaceuticsOpen Access

Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines

View Full Paper
Ask AI
Bookmark
Share

Authors

CWChung‐Pu WuSLSabrina LusvarghiJWJyun-Cheng Wang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wu et al. (2019) studied this question.

synapsesocial.com/papers/6a0c6c80d48675e494236cefhttps://doi.org/10.1021/acs.molpharmaceut.9b00274
View Full Paper
Ask AI
Bookmark
Share